Fortitude Advisory Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Fortitude Advisory Group's AMGN Position: Q2 2026 in Review
Fortitude Advisory Group reduced its Amgen (AMGN) stake by 1.4% in Q2 2026, selling an estimated $6.16K and leaving 1,258 shares worth $456K. The position accounts for 0.17% of the portfolio, ranked #116.
Fortitude Advisory Group first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $666K in Q4 2023. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Fortitude Advisory Group held 1,258 shares of Amgen worth $456K as of Q2 2026.
- Fortitude Advisory Group sold 18 Amgen shares in Q2 2026, an estimated $6.16K.
- Amgen made up 0.17% of Fortitude Advisory Group's portfolio in Q2 2026, its #116 holding.
- Fortitude Advisory Group first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- Fortitude Advisory Group's Amgen position peaked at $666K in Q4 2023.
- 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Fortitude Advisory Group's 13F filing for Q2 2026, filed 22 Jul 2026.